Mayfair Advisory Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
Mayfair Advisory Group's ZBH Position: Q2 2022 in Review
Mayfair Advisory Group sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 2,121 shares — an estimated $271K sold.
Mayfair Advisory Group first reported a position in ZBH in Q3 2021 and held it in 3 quarters. The position peaked at $271K in Q1 2022. 956 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.
- Mayfair Advisory Group reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
- Mayfair Advisory Group sold 2,121 Zimmer Biomet shares in Q2 2022, an estimated $271K.
- Mayfair Advisory Group first reported a position in Zimmer Biomet in Q3 2021 and held it in 3 quarters.
- Mayfair Advisory Group's Zimmer Biomet position peaked at $271K in Q1 2022.
- 956 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.
Based on Mayfair Advisory Group's 13F filing for Q2 2022, filed 9 Aug 2022.